Jessica Scott, MD
Glaucoma Specialist · East Orange, NJNPI 1386099695
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 32.5% of the total.
Across 137 payments — averaging $54.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sight Sciences, Inc.$2K
- Glaukos Corporation$1K
- Alcon$484
- Bausch & Lomb Americas Inc.$401
- Aerie Pharmaceuticals, Inc.$229
- plus $1K from 13 others
What the payments were for
- Travel & lodging$3114%
- Food & beverage$7,20396%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $2,444 |
| Sight Sciences, Inc. | 21 | $1,811 |
| Glaukos Corporation | 7 | $1,059 |
| Alcon | 18 | $484 |
| Bausch & Lomb Americas Inc. | 14 | $401 |
| Aerie Pharmaceuticals, Inc. | 3 | $229 |
| Tarsus Pharmaceuticals, Inc. | 2 | $216 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $143 |
| Astellas Pharma US Inc | 1 | $135 |
| Amgen | 7 | $116 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $115 |
| Biotissue Holdings Inc. | 2 | $110 |
| Dompe US, Inc. | 1 | $108 |
| Oyster Point Pharma, Inc. | 4 | $64 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Rayner Intraocular Lenses Limited | 1 | $18 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Ocular Therapeutix, Inc. | 1 | $16 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$1,513
- XEN GLAUCOMA TREATMENT SYSTEM$1,240
- SION SURGICAL INSTRUMENT$976
- iDose$341
- Tecnis IOL$286
- LUMIGAN$243
- Clareon$235
- enVista MX60 IOL$227
- XDEMVY$216
- iStent inject W$151
- IACCESS$151
- TEARCARE SYSTEM$144
- CATALYS SYSTEM$143
- Izervay$135
- MIEBO$125
- XIIDRA$125
- Rocklatan$119
- Rhopressa$119
- COMBIGAN$118
- Oxervate$108
How this compares
Too few glaucoma specialist providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 22 | $384 |
Paid to pharmacies, not to this prescriber.
Other glaucoma specialist in East Orange
- Paul LamaRochelle Park$72K
- Linda HuangRochelle Park$50K
- Alice WilliamsVineland$8K
- Matthew HoslerRahway$7K
- Gregory KramerWestfield$2K
- Sze WongOld Bridge$2K
- Omar Mobin-UddinNew Brunswick$1K
- Miriam HabielNewark$1K
- Khelly SavantClifton$774
- Linda ZhangWarren$610
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.